汉字News

← 汉字NewsChinese News for Learners
commerce
shāng yè
商业
·HSK 4

Merck (US pharmaceutical company)
Mòkè
默克
to announce
xuānbù
宣布
at / for (price)
yǐ
以
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
。

Merck company
Mòkè gōngsī
默克公司
to announce
xuānbù
宣布
at / for (price)
yǐ
以
approximately
yuē
约
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
，
to obtain / to acquire
huòqǔ
获取
its
qí
其
leukemia
báixuèbìng
白血病
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
。
this / the current
cǐ cì
此次
merger and acquisition
bìnggòu
并购
aimed at
zhǐzài
旨在
to strengthen / to bolster
qiánghuà
强化
Merck
Mòkè
默克
structural particle
de
的
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
，
to address / to cope with
yǐ yìngduì
以应对
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
patent
zhuānlì
专利
expiry / to expire
dàoqī
到期
structural particle
de
的
pressure / challenge
yālì
压力
。

March 25, 2026 at 6:00 PM

the United States
Měiguó
美国
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Merck company
Mòkè gōngsī
默克公司
on (date marker)
yú
于
March 25th
sānyuè èrshíwǔ rì
三月二十五日
announced
xuānbù
宣布
，
will / is to
jiāng
将
at / for (price)
yǐ
以
approximately
yuē
约
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
。
this / the current
cǐ cì
此次
acquisition
shōugòu
收购
at
yǐ
以
per share
měi gǔ
每股
$53 per share
53 měiyuán
53美元
structural particle
de
的
price
jiàgé
价格
to proceed / to be conducted
jìnxíng
进行
，
compared to
jiào
较
recent / near-term
jìnqī
近期
share price
gǔjià
股价
at a premium
yìjià
溢价
approximately
yuē
约
31 percent
31%
31%
。
excluding / after deducting
kòuchú
扣除
the acquired party
bèi shōugòu fāng
被收购方
cash
xiànjīn
现金
assets
zīchǎn
资产
after
hòu
后
，
actual / net
shíjì
实际
net
jìng
净
acquisition value
shōugòu é
收购额
approximately
yuē
约
is
wéi
为
$5.7 billion
57 yì měiyuán
57亿美元
。
deal / transaction
jiāoyì
交易
structural particle
de
的
core / central
héxīn
核心
asset
zīchǎn
资产
is
shì
是
Terns
Terns
Terns
company
gōngsī
公司
developed / R&D
yánfā
研发
structural particle
de
的
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
。
TERN-701 (drug candidate)
TERN-701
TERN-701
is
shì
是
a type of
yī zhǒng
一种
oral / taken by mouth
kǒufú
口服
small molecule
xiǎo fēnzǐ
小分子
targeted / targeted therapy
bǎxiàng
靶向
drug / medication
yàowù
药物
，
currently in the stage of
zhèng chǔyú
正处于
treating / treatment of
zhìliáo
治疗
chronic myeloid leukemia
mànxìng lì xìbāo báixuèbìng
慢性粒细胞白血病
structural particle
de
的
clinical trial
línchuáng shìyàn
临床试验
stage / phase
jiēduàn
阶段
。
analysts
fēnxī rénshì
分析人士
to believe / to consider
rènwéi
认为
，
TERN-701 (drug candidate)
TERN-701
TERN-701
has the potential to / is expected to
yǒuwàng
有望
to become
chéngwéi
成为
value / market worth
shìzhí
市值
multi-billion dollars
shù shí yì měiyuán
数十亿美元
structural particle
de
的
blockbuster / major
zhòngpàng
重磅
product
chǎnpǐn
产品
，
and / also
bìng
并
against / toward
duì
对
Novartis (pharmaceutical company)
Nuòhuá
诺华
under / subsidiary brand
qí xià
旗下
structural particle
de
的
Scemblix (leukemia drug by Novartis)
Scemblix
Scemblix
to pose / to constitute
gòuchéng
构成
competition
jìngzhēng
竞争
。
this
cǐ cì
此次
acquisition
bìnggòu
并购
is
shì
是
Merck
Mòkè
默克
in the past year
jìn yī nián
近一年
within
nèi
内
completed
wánchéng
完成
structural particle
de
的
the third
dì sān bǐ
第三笔
major / significant
zhòngdà
重大
acquisition
shōugòu
收购
，
aimed at
zhǐzài
旨在
to strengthen
qiánghuà
强化
its
qí
其
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
。
its
qí
其
flagship / star
míngxīng
明星
drug
yàowù
药物
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
structural particle
de
的
patent
zhuānlì
专利
will
jiāng
将
in
yú
于
the year 2028
2028 nián
2028年
expire / expiry
dàoqī
到期
。

News in English

Business

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion

Merck announced a deal worth roughly $6.7 billion to acquire Terns Pharmaceuticals and its leukemia drug candidate TERN-701. The deal is aimed at strengthening Merck cancer pipeline ahead of the patent expiry of flagship drug Keytruda in 2028.

More in Business

United States and Iran
Měi Yī
美伊
ceasefire
tínɡhuǒ
停火
news / information
xiāoxi
消息
to come in / to arrive (news)
chuánlái
传来
，
international
ɡuójì
国际
oil price
yóujià
油价
May
5 yuè
5月
to drop sharply / to fall significantly
dàdiē
大跌
17 percent
17%
17%
。

International Oil Prices Fall 17 Percent in May on US-Iran Ceasefire Reports

Snowflake (cloud data company)
Snowflake
Snowflake
quarterly / fiscal quarter
jìdù
季度
revenue / earnings
yínɡshōu
营收
to exceed / to surpass
chāochū
超出
expectations / forecast
yùqī
预期
，
and / also
bìng
并
with
yǔ
与
Amazon
Yàmǎxùn
亚马逊
to sign / to conclude
qiānshǔ
签署
$6 billion
60 yì měiyuán
60亿美元
agreement / deal
xiéyì
协议
。

Snowflake Quarterly Revenue Beats Forecasts and Signs $6 Billion Amazon Deal

China
Zhōngguó
中国
April
sì yuè
四月
industrial / industry
gōngyè
工业
profit
lìrùn
利润
to grow / growth
zēngzhǎng
增长
24.7 percent
24.7%
24.7%
。

China Industrial Profits Surge 24.7 Percent in April, Fastest Gain in Over Two Years

Meta (company name, formerly Facebook)
Meta
Meta
to lay off employees / layoffs
cáiyuán
裁员
8,000 people
bā qiān rén
八千人
，
to accelerate / to speed up
jiāsù
加速
toward / to
xiàng
向
artificial intelligence
réngōng zhìnéng
人工智能
business / operations
yèwù
业务
to transform / transformation
zhuǎnxíng
转型
。

Meta Cuts 8,000 Jobs in Sweeping Restructuring Toward AI